Advocate Aurora Health

Advocate Aurora Health Institutional Repository
Aurora St. Luke’s Medical Center Books,
Documents, and Pamphlets

Aurora St. Luke’s Medical Center

May 2015

History of Trans Myocardial Revascularization
Aurora Health Care

Follow this and additional works at: https://institutionalrepository.aah.org/aslmc_books
This Document is brought to you for free and open access by the Aurora St. Luke’s Medical Center at Advocate
Aurora Health Institutional Repository. It has been accepted for inclusion in Aurora St. Luke’s Medical Center Books,
Documents, and Pamphlets by an authorized administrator of Advocate Aurora Health Institutional Repository. For
more information, please contact AAH-Library@aah.org.

HISTORY OF
TRANS MYOCARDIAL REVtSCULARIZATION

1969

Hitt surgeon Mhmood Mithoseini, M.D., &nd his assistant M&ry
Cayton, R.N., visited Arneticen Optical Company in Boston to view an

industtial laser tiith the idea that it might be suitable fot use in
creating blood flow channe].s in the heart.

An experimental procedure

was performed there to test their concept.

1970

American Optical loaned the laser to Dr. Mihoseini for laboratory
study in Wausau, Wis.

The laser, approximately the size of a large

bed, was transported by train.

1970-75

To determine the safety and effectiveness of his laser treatment,
Mirhoseini conducted several years of experimental work on animals.
The studies showed the laser channels remained open, the surrounding
tissues experienced little damage, and the outer wall of the heert or
myocardium was protected from eschemia.

All of these studies were

performed on the beating heart, and the research was funded by the

United Fund of Marathon County.

1978

Mirhoseini began working to devise a laser procedure for use an
arrested heart in conjunction with bypass surgery until such time
that a high—powered laser could be developed for use on the beating

heart.

The laser would need to work fast enough to penetrate the

heart between its rhythmic pumping.

1983

firhoseini submitted a research proposal to St. Luke’s Medical Center
in Milwaukee to conduct the laser procedure using an existing low

powered carbon dioxide laser in conjunction with bypass surgery.

—
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—

1985

£lirhoseini performed his first Trans Myoc&rdial Revscu1erization
case in conjunction with bypess surgery &t St. Luke’s.

1985—87

Initial studies continued on 20 patients, nd these patients continue
to be closely followed.

Of these 20 patients with severe heart

disease, 18 continue to do well today and two died of untelted
cancers,

Autopsy results revealed the laser chernnels had remained

open and formed vessel—like walls.

These early studies were

supported by St. Luke’s Liedical Center Foundation, the Department of
Anesthesiology and Cardiac Surgery at the Medical College of
Wisconsin and the Clement Zablocki Veterans idministration Hospital.

1989

A prototype high—powered carbon dioxide laser was constructed by
Laser Engineering Inc. of Milford, Mass.

irhoseini experimented

with this laser to assure its safety and effectiveness.

1990

Seton Medical Center in San Francisco purchased a laser from Laser
Engineering Inc. and conducted Phase I clinical trials on the beating
hearts of 15 patients with end stage heart disease to determine the
safety of the laser.

1992

The FDA approved the laser for Phase II clinical studies to evaluate
the effectiveness of the laser procedure on 50 patients.

St. Luke’s

1”Iedical Center, Seton, Texas Heart Institute and Brigham & Women’s
Hospital in Boston were approved as study sites.

